# Cardiovascular system - BNF chapter 2

Source: https://www.rightdecisions.scot.nhs.uk/dgrefhelp-nhs-dumfries-galloway/dg-formulary/cardiovascular-system-bnf-chapter-2/
Fetched: 2026-02-23

## 1. Anti Arrhythmics


### Class I membrane stabilising drugs

- Flecainide


### Class II beta blockers

- Bisoprolol ✓ First Choice
- Carvedilol


### Class III anti-arrhythmic agents

- Sotalol
- Amiodarone
- Dronedarone – for the prevention of recurrence of AF in patients in whom beta-blockers, class 1c drugs or amiodarone are contraindicated, ineffective or not tolerated. ✓ Specialist Initiation Only


### Class IV calcium channel blockers (not to be used in patients with LVSD)

- Diltiazem - MR preparations should be prescribed by brand (Alizem XL®, Zemtard XL® capsules)Verapamil (Securon®) ✓ First Choice


### Other

- Atropine
- Adenosine


### Cardiac glycosides

- Digoxin ✓ First Choice

## 2. Bleeding disorders


### Anti-fibrinolytic drugs and haemostatics

- Tranexamic acid ✓ First Choice

## 3. Blood clots


### **Parenteral anticoagulants**


### Prophylaxis of DVT

- Dalteparin ✓ First Choice


### Treatment of DVT and/or PE

- Dalteparin ✓ First Choice


### Unstable angina and non-Q-wave MI

- Fonaparinux ✓ First Choice


### **Oral anticoagulants**


### Prevention of stroke and systemic embolism in patients with valvular AF, treatment of DVT and /or PE

- Warfarin ✓ First Choice


### Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation, treatment of DVT and /or PE

- Apixaban ✓ First Choice
- Edoxaban (where once daily dosing is desirable)
- Warfarin


### **Other** – Restricted to use only on advice of Consultant Haematologist in accordance with local protocol

- Idarucizumab (Praxibind®) injection/infusion ✓ Specialist Initiation Only
- Andexanet alfa (Ondexxya®) infusion ✓ Specialist Initiation Only

## 4. Blood pressure conditions

NICE Patient decision aid - HypertensionNICE: Hypertension in adults: diagnosis and treatment


### Angiotensin-converting enzyme inhibitors

- Ramipril capsules ✓ First Choice


#### Post stroke / prevention of vascular events in at risk patients

- Ramipril capsules ✓ First Choice

Angiotensin-II receptor antagonists

- Candesartan ✓ First Choice


### Calcium-channel blockers

- Amlodipine✓ First Choice/li>
- For long acting, once daily preparations - Adipine XL® (Nifedipine)


### Beta-adrenoceptor blocking drugs

- Bisoprolol ✓ First Choice


### Mineralocorticoid Receptor Antagonist (MRA)

- Spironolactone
- Eplerenone (used in men reduced risk of gynecomastia)


### Thiazides

- Indapamide ✓ First Choice
- Bendroflumethiazide


### Alpha-adrenoceptor blocking drugs

- Doxazosin ✓ First Choice

## 6. Heart Failure

For advice on prescribing in HF (heart failure) please contact the Heart Failure Nurse Specialists (HFNS) directly on dg.hf-referrals@nhs.scot.

Please do not stop any patient’s HF medications indefinitely without discussing with the HFNS first. If stopping for a period, please ensure they are reviewed for restarting when appropriate – the HFNS team can offer guidance with this.


### Heart Failure with reduced ejection Fraction (HF-rEF) - LVEF ≤40% 

Prescribe the 4 Pillars of Heart Failure:

- **Entresto**: If LVEF ≤40%, titrate up dose every 2–3 weeks (accept a little light-headedness if the patient stands up too quickly). Ensure ACE Inhibitors are **stopped 48 hours prior** to initiating Entresto.
- **Beta-blocker**: Bisoprolol or Carvedilol
- **Mineralocorticoid Receptor Antagonist (MRA)**: Spironolactone or Eplerenone (use Eplerenone in men to reduce risk of gynecomastia). MRAs can be used if potassium is 5.5 mmol/L, consider Lokelma (Sodium Zirconium Cyclosilicate) 5g daily – discuss with HFNS.
- **SGLT2 inhibitor**: Dapagliflozin or Empagliflozin (continue Empagliflozin if already prescribed for diabetes)


#### Diuretics

- Furosemide – starting dose 40mg OD
- Bumetanide
- Metolazone (Cardiology advice only)

If K+ >5.5 mmol/L, consider prescribing Lokelma (Sodium Zirconium Cyclosilicate).

For HF patients with eGFR above 30 ml/min, a rise in creatinine or fall in eGFR by up to 25% is acceptable. If more than this, contact HFNS for advice. The first drug to temporarily stop in mild AKI is the MRA (Eplerenone or Spironolactone).


### Heart Failure with mildly reduced Ejection Fraction (HFmrEF) - LVEF 41–49%

Treat the same as HF-rEF using the 4 pillars, but start with ACEi/ARB instead of Entresto.


### Heart Failure with preserved Ejection Fraction (HFpEF) - LVEF ≥50–55% with symptoms of HF and raised NTproBNP

SGLT2 inhibitor:

- Dapagliflozin or Empagliflozin (continue if already prescribed for diabetes)

**Hypertension treatment:**

- First line: ACEi (e.g. Ramipril)
- Second line: ARB (e.g. Candesartan)
- Note: ARB only if ACEi not tolerated (e.g. bradykinin cough or angioedema). No added benefit with Entresto if LVEF >40%.

**AF rate control**:

- Bisoprolol or Digoxin

**Oedema management**:

- Diuretics 

Furosemide
- Bumetanide
- (Metolazone by cardiology advice only)

## 7. Hyperlipidaemia

*Please see D&G Coronary Heart Disease and Stroke, Primary and Secondary Prevention Guideline*


### Primary Prevention

- Atorvastatin 20mg OD


### Secondary Prevention

- **Target LDLc <2mmol/L**

1st Line: Statins

- Atorvastatin / Rosuvastatin

If statin intolerant, please follow NICE guidelines: NICE Statin Intolerance Pathway

2nd Line:

- Ezetimibe

3rd Line:

- Bempedoic acid (Nilemdo®) or Bempedoic acid / Ezetimibe (Nustendi®)


#### Specialist Initiation

- Evolocumab (Repatha®) ✓ Specialist Initiation Only
- Alirocumab (Praluent®) – IPTR required ✓ Specialist Initiation Only
- Inclisiran (Leqvio®) ✓ Specialist Initiation Only

## 8. Anti-anginals


### Nitrates

- Glyceryl Trinitrate
- Isosorbide Mononitrate

*MR preparations are more cost effective; prescribe generically as MR 25/50mg caps or 40/60mg tabs.*


### Beta blocker

- Bisoprolol


### Ivabradine

- Ivabradine if in sinus rhythm and heart rate >70 bpm. If patient is in AF, use Beta-blocker (+ digoxin if needed for rate control).


### Calcium channel blocker

- Amlodipine


### Nicorandil

- Nicorandil – may be considered as add-on treatment or if intolerant to standard initial treatment.

If normal LV function, consider:

- Diltiazem (Adizem XL®, Zemtard XL® capsules)
- Verapamil (Securon®)


### Acute Coronary Syndrome

See guidance: NICE 185, SIGN 148

- Dual Antiplatelet therapy (consider PPI for gastro protection)
- ACEi/ARB
- Beta-blocker
- Statin
- GTN


### Antiplatelet

- Aspirin dispersible 75mg OD
- Clopidogrel 75mg OD
- Prasugrel 10mg OD – contraindicated in patients with a history of Stroke/TIA
- Ticagrelor 90mg BD – no longer being commenced but some existing patients may still be on it


### Sympathomimetics

- Adrenaline
- *Inotropic:* Dobutamine, Dopamine
- *Vasoconstrictor:* Noradrenaline acid tartrate


### Fibrinolytics

- *Acute myocardial infarction:* Tenecteplase
- *Stroke thrombolysis:* Alteplas

## 9. Oedema


### Loop diuretics

- Furosemide
- Bumetanide


### Thiazide and related diuretics

- Metolazone (Cardiology advice only)


### Aldosterone antagonist

- Spironolactone – avoid in men where possible due to risk of gynecomastia

